We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Product News   Oct 16, 2020

 
Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience

Credit: Joshua Coleman/ Unsplash

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

InSphero Strengthens Scientific Advisory Board To Advance Drug Discovery and Safety Solutions

Product News

InSphero AG, today announced the strengthening of its Scientific Advisory Board (SAB).

READ MORE

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics

Product News

FairJourney Biologics S.A (FJB) and IONTAS Limited (IONTAS) today announced they have signed an agreement to discover antibodies with Pandion Therapeutics (Pandion).

READ MORE

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE